跳至主要内容
临床试验/NCT01886781
NCT01886781已完成4 期

Randomised Controlled Trial: Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome

University of Stellenbosch1 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
81
试验地点
1
主要终点
A Change in Abdominal Pain Severity

研究概览

简要总结

In patients with IBS, will supplementation with a probiotic demonstrate symptomatic efficacy and will the probiotic influence gut microflora and thus improve clinical outcomes, as compared to no intervention.

详细描述

Conduct a study on nutrient intakes gastrointestinal microbiota and the effect of a probiotic, Lactobacillus plantarum 299v in irritable bowel syndrome patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • fulfillment of the Rome II criteria for IBS,
  • availability of at least one colonoscopy within the last three years,
  • aged 18 or older at the time of screening,
  • provision of written informed consent,
  • commitment of availability throughout the 12 week study period.

排除标准

  • major abdominal surgery in the past other than other than appendectomy, caesarean section, tubal laparoscopic cholecystectomy, abdominal wall hernia repair or/and hysterectomy,
  • current use of antibiotics,
  • history of organic intestinal disease,
  • pregnant or breastfeeding mothers,
  • chronic infectious disease like HIV or tuberculosis, and
  • unable to understand English or Afrikaans.

研究组 & 干预措施

Lactobacillus plantarum 299v

Experimental

Lactobacillus plantarum 299v capsules

干预措施: Lactobacillus plantarum 299v (Drug)

Lactobacillus plantarum 299v

Experimental

Lactobacillus plantarum 299v capsules

干预措施: Run in period (Other)

Lactobacillus plantarum 299v

Experimental

Lactobacillus plantarum 299v capsules

干预措施: Wash - out period (Other)

Crytalline cellulose powder

Placebo Comparator

Placebo capsule, filled with micro-crystalline cellulose powder

干预措施: Placebo comparator (Drug)

Crytalline cellulose powder

Placebo Comparator

Placebo capsule, filled with micro-crystalline cellulose powder

干预措施: Run in period (Other)

Crytalline cellulose powder

Placebo Comparator

Placebo capsule, filled with micro-crystalline cellulose powder

干预措施: Wash - out period (Other)

结局指标

主要结局

A Change in Abdominal Pain Severity

时间窗: Total trial period 12 weeks

The clinical severity of the IBS symptoms (pain and distension) was evaluated by the Francis Severity Score questionnaire (Francis 1997). The questionnaire is a validated tools for use in IBS. The severity score contained five questions, each given a value from 0 (no symptoms) to 100 (most severe) for measuring the severity and frequency of abdominal pain. The sum of scores of these questions was considered the severity score, with a maximum possible score of 500

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cheryl Stevenson

Mrs

University of Stellenbosch

研究点 (1)

Loading locations...

相似试验